Dina EL Salmy

Takeda, ICMEA Head of Portfolio Management Growth & Emerging Markets Business Unit

Dina El Salmy is the Head of Portfolio Management, Growth & Emerging Markets Business Unit at Takeda Pharmaceuticals in the ICMEA region, which includes India, CIS, the Middle East, Turkey and Africa. She builds on more than 20 years of experience and extensive operational expertise in sales, marketing, digital marketing, and quality assurance/control from Shire, Amgen, Pfizer, Wyeth, Novartis Consumer Health and Bristol Myers Squibb.

El Salmy is a performance-driven professional with a strong track record in different therapeutic areas, including oncology, immuno-oncology, hematology, nephrology, cardiovascular disease, antibiotics, antifungals, rare diseases, genetic diseases, neuroscience, inflammation, immunology, ophthalmology, vaccines, dermatology, rheumatology, biosimilars, diagnostics, medical nutrition, women’s health, and
consumer health.

In her current capacity, El Salmy leads the marketing department across all franchises in the region. With a background in pharmacy, marketing and senior strategic leadership, El Salmy’s expertise in the pharmaceutical industry, along with her ability to lead teams to exceed business objectives reflects her strategic insight and passion.

Articles by Dina EL Salmy

Gender Equality at Takeda

A Takeda portfolio management leader on 20 years in pharma and why her ICMEA region's workforce is now 58% women. See open roles at Takeda today.